The Edward Neurosciences Institute has been officially recognized as a Partner in MS Care in Neurologic Care through the National Multiple Sclerosis Society’s Partners in MS Care program. This formal recognition honors the Institute’s commitment to providing exceptional, coordinated MS care and a continuing partnership with the Society to address the challenges of people affected by MS.
The Society’s Partners in MS Care program recognizes committed providers whose practices support the Society’s initiative of affordable access to high quality MS healthcare for everyone living with MS – regardless of geography, disease progression and other disparities.
The Edward Neurosciences Institute provides MS care through its MS Clinic in Warrenville at 3S517 Winfield Rd., where Henry Echiverri, MD is medical director. Dr. Echiverri is a board certified neurologist with more than 20 years of experience working with patients who have MS and other neurological disorders. In addition, a physician assistant and nurse with special training in MS care are on staff at the Clinic, which is linked to a network of neurologists, social workers, and physical, speech and occupational therapists.
The Clinic offers initial diagnosis, second opinion and/or treatment, most of which can be done at the Warrenville location. MS treatment options include traditional steroid injections and the latest oral medications, and newer, more innovative treatments, such as plasma exchange or chemotherapy involving cancer drugs combined with steroids. Most treatments can be done at the Clinic, except infusion treatments for certain patients, which are provided at the Edward Cancer Centers in Naperville and Plainfield.
Multiple sclerosis is an unpredictable, often disabling disease of the central nervous system that disrupts the flow of information within the brain, and between the brain and body.
Symptoms vary from person to person and range from numbness and tingling, to walking difficulties, fatigue, dizziness, pain, depression, blindness and paralysis. The progress, severity and specific symptoms of MS in any one person cannot yet be predicted, but advances in research and treatment are leading to better understanding and moving us closer to a world free of MS. Most people with MS are diagnosed between the ages of 20 and 50, with at least two to three times more women than men being diagnosed with the disease. MS affects more than 2.3 million worldwide.
Learn more about the National Multiple Sclerosis Society’s Partners in MS Care program
Learn more about the Edward Neurosciences Institute’s MS Clinic.